Clinical Trial Update: Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety and efficacy of high-dose, rapid-titration galantamine in Alzheimer's disease; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• galantamine (Razadyne) (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Alzheimer's Disease, Dementia | Phase 3 | Status: COMPLETED